Comparison between Amar Remedies IPO and Vivimed Labs IPO.
Amar Remedies IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Vivimed Labs IPO is a Mainboard Fixed Price proposed to list at BSE, NSE.
| Amar Remedies IPO | Vivimed Labs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Almondz Global Securities Ltd. | Standard Chartered Securities (India) Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Aarthi Consultants Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Amar Remedies IPO is up to ₹42.00 Cr whereas the issue size of the Vivimed Labs IPO is up to ₹17.51 Cr. The final issue price of Amar Remedies IPO is ₹28.00 per share and of Vivimed Labs IPO is ₹70.00 per share.
| Amar Remedies IPO | Vivimed Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹24.00 per share | |
| Issue Price (Upper) | ₹28.00 per share | |
| Issue Price (Final) | ₹28.00 per share | ₹70.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,50,00,000 shares | 25,01,429 shares |
| Fresh Issue Size (Amount) | up to ₹42.00 Cr | up to ₹17.51 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,50,00,000 shares | 25,01,429 shares |
| Issue Size Total (Amount) | up to ₹42.00 Cr | up to ₹17.51 Cr |
Amar Remedies IPO opens on Aug 25, 2005, while Vivimed Labs IPO opens on Jul 09, 2005. The closing date of Amar Remedies IPO and Vivimed Labs IPO is Aug 31, 2005, and Jul 13, 2005, respectively.
| Amar Remedies IPO | Vivimed Labs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2005 | Jul 09, 2005 |
| Issue Close | Aug 31, 2005 | Jul 13, 2005 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 16, 2005 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Amar Remedies IPO P/E ratio is 4.63, as compared to Vivimed Labs IPO P/E ratio of .
| Amar Remedies IPO | Vivimed Labs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 55.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 42.67 | 36.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 4.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹73.26 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.47 | 23.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Amar Remedies IPO Retail Individual Investors (RII) are offered 52,50,000 shares while in Vivimed Labs IPO retail investors are offered 52,50,000 shares. Qualified Institutional Buyers (QIB) are offered 75,00,000 shares in Amar Remedies IPO and 0 shares in Vivimed Labs IPO.
| Amar Remedies IPO | Vivimed Labs IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 75,00,000 shares | 0 shares |
| NII | 22,50,000 shares | 9,25,000 shares |
| RII | 52,50,000 shares | 9,25,000 shares |
| Employee | 0 shares | 50,000 shares |
| Others | ||
| Total | 1,50,00,000 shares | 25,00,000 shares |
Amar Remedies IPO subscribed in total, whereas Vivimed Labs IPO subscribed .
